Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Apple News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Apple News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why a 25-cent pill is being sold to cancer patients for nearly $1,000

26:43
 
Share
 

Manage episode 485643294 series 3344765
Content provided by Apple News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Apple News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

When ProPublica health-care reporter David Armstrong was diagnosed with a rare blood cancer, he began taking a lifesaving drug called Revlimid. When he learned that each pill of this medication is sold for nearly $1,000 but costs drug companies only cents to make, he went on a quest to uncover the reasons behind its shocking price tag. Armstrong sat down with Apple News In Conversation host Shumita Basu to talk about his investigation into Revlimid’s origins and what it reveals about prescription-drug pricing in America.

  continue reading

188 episodes

Artwork
iconShare
 
Manage episode 485643294 series 3344765
Content provided by Apple News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Apple News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

When ProPublica health-care reporter David Armstrong was diagnosed with a rare blood cancer, he began taking a lifesaving drug called Revlimid. When he learned that each pill of this medication is sold for nearly $1,000 but costs drug companies only cents to make, he went on a quest to uncover the reasons behind its shocking price tag. Armstrong sat down with Apple News In Conversation host Shumita Basu to talk about his investigation into Revlimid’s origins and what it reveals about prescription-drug pricing in America.

  continue reading

188 episodes

כל הפרקים

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play